Vasopressin of no benefit in cardiopulmonary resuscitation?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1646, 2008-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potential of vasopressin in cardiopulmonary resuscitation

By Salam Amar Mohammad

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 517-520

Informa Healthcare

Access to resources Recommend Favorite

Vasopressin During Cardiopulmonary Resuscitation and Different Shock States: A Review of the Literature

By Krismer Anette C.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 1, 2006-01 ,pp. : 51-68

Adis International

Access to resources Recommend Favorite

Olprinone beneficial after cardiopulmonary bypass?

Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Cost-benefit or cost-utility analysis?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Thrombolytics: no survival benefit in patients aged > 75 years?

Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite